Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04750642 · ClinicalTrials.gov registry record · NA

Cochlear Implant With Dexamethasone Eluting Electrode Array

A NA study of Sensorineural Hearing Loss and Bilateral Hearing Loss, sponsored by Cochlear.

Completed
Registry status
NA
Development phase
42
Enrollment target
8
Study locations

NCT04750642 is a NA study of Sensorineural Hearing Loss and Bilateral Hearing Loss that has completed, run by Cochlear. The registered enrollment target is 42 participants, below the 128-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (67% lower). The trial reports 8 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04750642, a NA study of Sensorineural Hearing Loss and Bilateral Hearing Loss, has completed, sponsored by Cochlear.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target
8
Study locations

Study Summary

An evaluation of Cochlear's cochlear implant electrode array which passively elutes dexamethasone for a defined period of time to help reduce inflammatory responses.

Interventions

  • DEVICE CI632D
  • DEVICE CI632

Study Locations (8)

New York

  • New York Eye & Ear infirmary of Mt. Sinai - New York
  • NYU Langone Medical Center - New York

New South Wales

  • Fiona Stanley Hospital - Murdoch
  • Westmead Hospital - Sydney

Colorado

  • Rocky Mountain Ear Centre - Englewood

Iowa

  • University of Iowa - Iowa City

Victoria

  • Royal Victorian Eye and Ear Hospital - East Melbourne

Other

  • Gilles Hospital - Auckland

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2021-10-04
Est. Completion 2024-02-23
Phase NA

Sponsor

Cochlear

34 total trials

What the Registry Record Tells You About NCT04750642

The ClinicalTrials.gov registry entry for NCT04750642 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 128-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (67% lower). The listed sponsor is Cochlear, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Sensorineural Hearing Loss appearing as the primary indexed condition, and to 2 interventions - of which CI632D is the first listed.

NCT04750642 reports 8 study locations spanning 6 distinct geographic areas - top geographies include New York, New South Wales, Colorado.

Frequently Asked Questions

What is clinical trial NCT04750642 about?

NCT04750642 is a clinical study titled "Cochlear Implant With Dexamethasone Eluting Electrode Array". An evaluation of Cochlear's cochlear implant electrode array which passively elutes dexamethasone for a defined period of time to help reduce inflammatory responses.

What is the current status of trial NCT04750642?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2021-10-04. Estimated completion is 2024-02-23.

What conditions does trial NCT04750642 study?

This clinical trial studies the following conditions: Sensorineural Hearing Loss, Bilateral Hearing Loss.

What interventions are being tested in trial NCT04750642?

The interventions under investigation include: CI632D (DEVICE), CI632 (DEVICE).

Who is sponsoring clinical trial NCT04750642?

This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04750642 being conducted?

This trial has 8 study locations across Colorado, Iowa, New York, New South Wales, Victoria. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sensorineural Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.